347 related articles for article (PubMed ID: 33959755)
21. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
[TBL] [Abstract][Full Text] [Related]
22. The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells.
Ma L; Vidana Gamage HE; Tiwari S; Han C; Henn MA; Krawczynska N; Dibaeinia P; Koelwyn GJ; Das Gupta A; Bautista Rivas RO; Wright CL; Xu F; Moore KJ; Sinha S; Nelson ER
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35569056
[TBL] [Abstract][Full Text] [Related]
23. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
[TBL] [Abstract][Full Text] [Related]
24. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.
Henrich SE; McMahon KM; Plebanek MP; Calvert AE; Feliciano TJ; Parrish S; Tavora F; Mega A; De Souza A; Carneiro BA; Thaxton CS
J Extracell Vesicles; 2020 Dec; 10(2):e12042. PubMed ID: 33408816
[TBL] [Abstract][Full Text] [Related]
26. Tumor cell-released LC3-positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation.
Sun X; Wang X; Yan C; Zheng S; Gao R; Huang F; Wei Y; Wen Z; Chen Y; Zhou X; Liu X; Chen B; Shen Y; Cai Y; Pan N; Wang L
Cancer Sci; 2022 Oct; 113(10):3405-3416. PubMed ID: 35879596
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
[TBL] [Abstract][Full Text] [Related]
29. Obesity, cholesterol metabolism, and breast cancer pathogenesis.
McDonnell DP; Park S; Goulet MT; Jasper J; Wardell SE; Chang CY; Norris JD; Guyton JR; Nelson ER
Cancer Res; 2014 Sep; 74(18):4976-82. PubMed ID: 25060521
[TBL] [Abstract][Full Text] [Related]
30. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.
Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ
Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice.
Yu L; Xu L; Chu H; Peng J; Sacharidou A; Hsieh HH; Weinstock A; Khan S; Ma L; Durán JGB; McDonald J; Nelson ER; Park S; McDonnell DP; Moore KJ; Huang LJ; Fisher EA; Mineo C; Huang L; Shaul PW
Nat Commun; 2023 Jul; 14(1):4101. PubMed ID: 37491347
[TBL] [Abstract][Full Text] [Related]
32. 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.
He S; Nelson ER
Maturitas; 2017 Oct; 104():29-35. PubMed ID: 28923174
[TBL] [Abstract][Full Text] [Related]
33. The ROS-mediated activation of IL-6/STAT3 signaling pathway is involved in the 27-hydroxycholesterol-induced cellular senescence in nerve cells.
Liu J; Liu Y; Chen J; Hu C; Teng M; Jiao K; Shen Z; Zhu D; Yue J; Li Z; Li Y
Toxicol In Vitro; 2017 Dec; 45(Pt 1):10-18. PubMed ID: 28739487
[TBL] [Abstract][Full Text] [Related]
34. αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3.
Zhang DX; Dang XTT; Vu LT; Lim CMH; Yeo EYM; Lam BWS; Leong SM; Omar N; Putti TC; Yeh YC; Ma V; Luo JY; Cho WC; Chen G; Lee VKM; Grimson A; Le MTN
J Extracell Vesicles; 2022 Aug; 11(8):e12234. PubMed ID: 35923105
[TBL] [Abstract][Full Text] [Related]
35. Extracellular Vesicles and Bone-Associated Cancer.
Dai J; Shupp AB; Bussard KM; Keller ET
Curr Osteoporos Rep; 2021 Jun; 19(3):223-229. PubMed ID: 33638774
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
[TBL] [Abstract][Full Text] [Related]
37. Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study.
DeRouen MC; Yang J; Li Y; Franke AA; Tome AN; White KK; Hernandez BY; Shvetsov Y; Setiawan V; Wu AH; Wilkens LR; Le Marchand L; Loo LWM; Cheng I
Breast Cancer Res; 2023 Aug; 25(1):95. PubMed ID: 37580793
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression.
Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X
FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
40. The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.
McDonnell DP; Chang CY; Nelson ER
Climacteric; 2014 Dec; 17 Suppl 2(0 2):60-5. PubMed ID: 25320023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
